Drug intelligence / Profile preview

Respilac

Development stage
Unknown
Lead developer
Sooft Italia
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Respilac is a preservative-free ophthalmic solution developed by Sooft Italia Spa for the treatment of moderate dry eye disease (DED), particularly in contact lens wearers. The formulation contains 2.0% lipidure (2-methacryloyloxyethyl phosphorylcholine, or MPC) and 0.1% hypromellose (HPMC). Lipidure is a biomimetic polymer characterized by high biological compatibility and moisture retention, which protects corneal epithelial cells and contact lenses from desiccation damage. Hypromellose serves as a lubricant and viscosity-increasing agent to stabilize the tear film and reduce ocular surface stress. Clinical studies have demonstrated that Respilac is non-inferior to standard HPMC-based artificial tears in improving ocular tolerability and reducing symptoms such as burning, itching, and foreign body sensation.

Brand names
Respilac
Other names
lipidure + hypromellose ophthalmic solutionMPC + HPMC ophthalmic solution

Beyond the preview

Go deeper on Respilac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respilac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call